Restructuring the business to give its pharma and cosmetics operations “greater entrepreneurial responsibility” paid off for Weleda in 2024 as the Swiss firm reported the highest revenues in its 100+ year history.
Group sales advanced by 8.3% to €456m ($501m) in the year Weleda introduced its dedicated Natural Cosmetics and Pharmaceuticals business units
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?